Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Esophagus to Small Intestine

    Efficacy and safety of 48 weeks of guselkumab for patients with Crohn’s disease: Maintenance results from the phase 2, randomized, double-blind GALAXI-1 trial

    Lancet Gastroenterol Hepatol. 2024;9(2):133–46

    Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D’Haens GR; GALAXI-1 Study Group

    Go to article

    Esophagus to Small Intestine

    A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): A multicenter, open-label randomized controlled trial

    Lancet Gastroenterol Hepatol. 2024;9(5):415–27

    Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D’Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M; PROFILE Study Group

    Go to article

    Colon to Rectum

    Tumor necrosis factor inhibitors in inflammatory bowel disease and risk of immune-mediated inflammatory diseases

    Clin Gastroenterol Hepatol. 2024;22(1):135–43.e8

    Ward D, Nyboe Andersen N, Gørtz S, Thorn Iversen A, Højgaard Allin K, Beaugerie L, Kirchgesner J, Jess T

    Go to article

    Colon to Rectum

    Proton-pump inhibitors and risk of enteric infection in inflammatory bowel disease: A self-controlled case series

    Inflamm Bowel Dis. 2024;30(1):38–44

    Varma S, Trudeau SJ, Li J, Freedberg DE

    Go to article

    Colon to Rectum

    Absolute and relative risks of kidney and urological complications in patients with inflammatory bowel disease

    Am J Gastroenterol. 2024;119(1):138–46

    Yang Y, Ludvigsson JF, Olén O, Sjölander A, Carrero JJ

    Go to article

    Colon to Rectum

    Curcumin-QingDai combination for patients with active ulcerative colitis: A randomized, double-blinded, placebo-controlled trial

    Clin Gastroenterol Hepatol. 2024;22(2):347–56.e6

    Ben-Horin S, Salomon N, Karampekos G, Viazis N, Lahat A, Ungar B, Eliakim R, Kuperstein R, Kriger-Sharabi O, Reiss-Mintz H, Yanai H, Dotan I, Zittan E, Maharshak N, Hirsch A, Weitman M, Mantzaris GJ, Kopylov U

    Go to article

    Colon to Rectum

    Outcome of biological therapies and small molecules in ulcerative proctitis: A Belgian multicenter cohort study

    Clin Gastroenterol Hepatol. 2024;22(1):154–63.e3

    Lemmens P, Louis E, Van Moerkercke W, Pouillon L, Somers M, Peeters H, Vanden Branden S, Busschaert J, Baert F, Cremer A, Potvin P, Dewit S, Colard A, Swinnen J, Lambrecht G, Claessens C, Willandt B, Dewint P, Van Dyck E, Sabino J, Vermeire S, Ferrante M

    Go to article

    Colon to Rectum

    Hormonal contraceptives reduce active symptomatic disease but may increase intestinal inflammation in IBD

    J Clin Gastroenterol. 2024;58(3):271–6

    Dolovich C, Shafer LA, Graff LA, Vagianos K, Witges K, Targownik LE, Bernstein CN

    Go to article

    Colon to Rectum

    Short-term psychodynamic psychotherapy in addition to standard medical therapy increases clinical remission in adolescents and young adults with inflammatory bowel disease: A randomized controlled trial

    J Crohns Colitis. 2024;18(2):256–63

    Milo F, Imondi C, D’Amore C, Angelino G, Knafelz D, Bracci F, Dall’Oglio L, De Angelis P, Tabarini P

    Go to article